212 related articles for article (PubMed ID: 25620068)
1. Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.
Rassu G; Soddu E; Cossu M; Brundu A; Cerri G; Marchetti N; Ferraro L; Regan RF; Giunchedi P; Gavini E; Dalpiaz A
J Control Release; 2015 Mar; 201():68-77. PubMed ID: 25620068
[TBL] [Abstract][Full Text] [Related]
2. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.
Farr AC; Xiong MP
Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
[TBL] [Abstract][Full Text] [Related]
4. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
[TBL] [Abstract][Full Text] [Related]
5. Methyl-β-cyclodextrin quaternary ammonium chitosan conjugate: nanoparticles vs macromolecular soluble complex.
Piras AM; Fabiano A; Chiellini F; Zambito Y
Int J Nanomedicine; 2018; 13():2531-2541. PubMed ID: 29731628
[TBL] [Abstract][Full Text] [Related]
6. Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization.
Lopedota A; Cutrignelli A; Laquintana V; Denora N; Iacobazzi RM; Perrone M; Fanizza E; Mastrodonato M; Mentino D; Lopalco A; Depalo N; Franco M
Pharm Res; 2016 Sep; 33(9):2195-208. PubMed ID: 27245467
[TBL] [Abstract][Full Text] [Related]
7. Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases.
Rassu G; Salis A; Porcu EP; Giunchedi P; Roldo M; Gavini E
Carbohydr Polym; 2016 Jan; 136():1338-47. PubMed ID: 26572479
[TBL] [Abstract][Full Text] [Related]
8. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.
Giuliani A; Balducci AG; Zironi E; Colombo G; Bortolotti F; Lorenzini L; Galligioni V; Pagliuca G; Scagliarini A; Calzà L; Sonvico F
Drug Deliv; 2018 Nov; 25(1):376-387. PubMed ID: 29382237
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
10. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
11. The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability.
Rassu G; Ferraro L; Pavan B; Giunchedi P; Gavini E; Dalpiaz A
Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30373187
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive microspheres for nasal administration of cyclodextrins.
Gavini E; Rassu G; Haukvik T; Lanni C; Racchi M; Giunchedi P
J Drug Target; 2009 Feb; 17(2):168-79. PubMed ID: 18985506
[TBL] [Abstract][Full Text] [Related]
13. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
Bshara H; Osman R; Mansour S; El-Shamy Ael-H
Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
[TBL] [Abstract][Full Text] [Related]
14. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y
Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997
[TBL] [Abstract][Full Text] [Related]
15. Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation.
Papakyriakopoulou P; Manta K; Kostantini C; Kikionis S; Banella S; Ioannou E; Christodoulou E; Rekkas DM; Dallas P; Vertzoni M; Valsami G; Colombo G
Int J Pharm; 2021 Sep; 607():121016. PubMed ID: 34411652
[TBL] [Abstract][Full Text] [Related]
16. Brain uptake of an anti-ischemic agent by nasal administration of microparticles.
Dalpiaz A; Gavini E; Colombo G; Russo P; Bortolotti F; Ferraro L; Tanganelli S; Scatturin A; Menegatti E; Giunchedi P
J Pharm Sci; 2008 Nov; 97(11):4889-903. PubMed ID: 18300305
[TBL] [Abstract][Full Text] [Related]
17. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
[TBL] [Abstract][Full Text] [Related]
18. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
[TBL] [Abstract][Full Text] [Related]
19. PLGA/DPPC/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment.
Karavasili C; Bouropoulos N; Sygellou L; Amanatiadou EP; Vizirianakis IS; Fatouros DG
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():1053-1062. PubMed ID: 26652464
[TBL] [Abstract][Full Text] [Related]
20. Carboxymethyl β-cyclodextrin grafted carboxymethyl chitosan hydrogel-based microparticles for oral insulin delivery.
Yang Y; Liu Y; Chen S; Cheong KL; Teng B
Carbohydr Polym; 2020 Oct; 246():116617. PubMed ID: 32747257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
